Phil Low and his impact on Purdue innovation and commercialization

January 5, 2022

Phil Low and his impact on Purdue innovation and commercialization

*Phil Low and Timothy L. Ratliff, Ph.D., Distinguished Professor, Comparative Pathobiology; Robert Wallace Miller Director, Purdue Center for Cancer Research. (Purdue Department of Chemistry photo)*

Congratulations to Phil Low and On Target Laboratories: the U.S. Food and Drug Administration has approved the company’s innovation to illuminate ovarian cancer cells during surgery.

Low is the Presidential Scholar for Drug Discovery and Ralph C. Corley Distinguished Professor of Chemistry — Biochemistry in Purdue University’s Department of Chemistry. He has created and developed hundreds of innovations during his tenure.

Today we look at some of the impact that Low and his innovation and commercialization success have had at Purdue. Thanks to everyone who shared in their own words how Phil Low has impacted them.